Dogwood Therapeutics, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 27, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jan 30, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Sep 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Apr 23, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $10 | 44% |
No cross-platform signals in the last 90 days